1033 related articles for article (PubMed ID: 30016571)
21. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G
Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466
[TBL] [Abstract][Full Text] [Related]
22. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.
Lim S; Park J; Shim MK; Um W; Yoon HY; Ryu JH; Lim DK; Kim K
Theranostics; 2019; 9(25):7906-7923. PubMed ID: 31695807
[TBL] [Abstract][Full Text] [Related]
23. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
[TBL] [Abstract][Full Text] [Related]
24. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
[TBL] [Abstract][Full Text] [Related]
25. Targeting immunogenic cell stress and death for cancer therapy.
Galluzzi L; Guilbaud E; Schmidt D; Kroemer G; Marincola FM
Nat Rev Drug Discov; 2024 Jun; 23(6):445-460. PubMed ID: 38622310
[TBL] [Abstract][Full Text] [Related]
26. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
Wang J; Ma J; Xie F; Miao F; Lv L; Huang Y; Zhang X; Yu J; Tai Z; Zhu Q; Bao L
Front Immunol; 2024; 15():1389173. PubMed ID: 38745666
[TBL] [Abstract][Full Text] [Related]
27. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment.
Hou X; Tao Y; Pang Y; Li X; Jiang G; Liu Y
Int J Cancer; 2018 Dec; 143(12):3050-3060. PubMed ID: 29981170
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy.
Li W; Jiang Y; Lu J
Int J Pharm; 2023 Mar; 634():122655. PubMed ID: 36720448
[TBL] [Abstract][Full Text] [Related]
30. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
[TBL] [Abstract][Full Text] [Related]
31. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
Yu S; Xiao H; Ma L; Zhang J; Zhang J
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
33. Rational design of ICD-inducing nanoparticles for cancer immunotherapy.
Zhang Z; Pan Z; Li Q; Huang Q; Shi L; Liu Y
Sci Adv; 2024 Feb; 10(6):eadk0716. PubMed ID: 38324678
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment.
Rajendrakumar SK; Uthaman S; Cho CS; Park IK
Biomacromolecules; 2018 Jun; 19(6):1869-1887. PubMed ID: 29677439
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
Liu J; Zhang R; Xu ZP
Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
[TBL] [Abstract][Full Text] [Related]
36. The inducers of immunogenic cell death for tumor immunotherapy.
Li X
Tumori; 2018; 104(1):1-8. PubMed ID: 28967094
[TBL] [Abstract][Full Text] [Related]
37. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
[TBL] [Abstract][Full Text] [Related]
38. Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death-Induced Cancer Immunotherapy.
Liu Y; Chang R; Xing R; Yan X
Small Methods; 2023 May; 7(5):e2201708. PubMed ID: 36720041
[TBL] [Abstract][Full Text] [Related]
39. Near-Infrared Photoimmunotherapy of Cancer.
Kobayashi H; Choyke PL
Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
[TBL] [Abstract][Full Text] [Related]
40. Polymeric Nanosystems for Immunogenic Cell Death-Based Cancer Immunotherapy.
Fu L; Zhou X; He C
Macromol Biosci; 2021 Jul; 21(7):e2100075. PubMed ID: 33885225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]